• Publications
  • Influence
Genetics of osteoporosis
  • 583
  • 39
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes.
CONTEXT Previous observations showed a condition of low bone turnover and decreased osteoblast activity in both type 1 and 2 diabetes mellitus (DM1 and DM2). Sclerostin is a secreted Wnt antagonistExpand
  • 119
  • 8
  • PDF
Prevalence of Paget's Disease of Bone in Italy
We examined the prevalence of PDB in Italy from radiological, scintigraphic, and biochemical surveys in two Italian towns. Prevalence rates varied from 0.7% to 2.4%, were higher in males than inExpand
  • 82
  • 8
Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study
SummaryThis study aimed to evaluate the prevalence of vertebral fractures to investigate the determinants of vertebral fracture risk in patients with COPD. The risk of vertebral fractures is strictlyExpand
  • 99
  • 7
Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men.
Male osteoporosis is an increasingly important health problem. It is known that sex steroid hormones play an important role in regulating bone turnover and bone mass in males as well as in females.Expand
  • 223
  • 6
  • PDF
Aromatase activity and bone homeostasis in men.
It is known that sex steroid hormones play an important role in the maintenance of bone mass in males as well as in females. Even though androgens are the major sex steroids in men, their primacy inExpand
  • 152
  • 6
Endocrine Actions of Osteocalcin
Osteocalcin is the most abundant noncollagenous protein of bone matrix. Once transcribed, this protein undergoes posttranslational modifications within osteoblastic cells before its secretion,Expand
  • 99
  • 6
  • PDF
SQSTM1 gene analysis and gene‐environment interaction in Paget's disease of bone
Even though SQSTM1 gene mutations have been identified in a consistent number of patients, the etiology of Paget's disease of bone (PDB) remains in part unknown. In this study we analyzed SQSTM1Expand
  • 63
  • 6
Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome.
BACKGROUND Although anemia is frequently found in congestive heart failure (CHF), little is known about the effect of its correction with erythropoietin (EPO) on cardiac structure and function. Expand
  • 134
  • 5
Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
BACKGROUND Anemia is now recognized as being a common finding in CHF and is associated with increased mortality and morbidity. However, it is uncertain whether the anemia is actually causing theExpand
  • 190
  • 5